Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway

Patrick Viatour, Ursula Ehmer, Louis A. Saddic, Craig Dorrell, Jesper B. Andersen, Chenwei Lin, Anne Flore Zmoos, Pawel K. Mazur, Bethany E. Schaffer, Austin Ostermeier, Hannes Vogel, Karl G. Sylvester, Snorri S. Thorgeirsson, Markus Grompe, Julien Sage

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/ progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.

Original languageEnglish (US)
Pages (from-to)1963-1976
Number of pages14
JournalJournal of Experimental Medicine
Volume208
Issue number10
DOIs
StatePublished - Sep 26 2011

Fingerprint

Retinoblastoma
Hepatocellular Carcinoma
Stem Cells
Liver
Neoplasms
E2F Transcription Factors
Retinoblastoma Genes
Transcriptome
Epigenomics
Knockout Mice
Survival
Growth

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Viatour, P., Ehmer, U., Saddic, L. A., Dorrell, C., Andersen, J. B., Lin, C., ... Sage, J. (2011). Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. Journal of Experimental Medicine, 208(10), 1963-1976. https://doi.org/10.1084/jem.20110198

Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. / Viatour, Patrick; Ehmer, Ursula; Saddic, Louis A.; Dorrell, Craig; Andersen, Jesper B.; Lin, Chenwei; Zmoos, Anne Flore; Mazur, Pawel K.; Schaffer, Bethany E.; Ostermeier, Austin; Vogel, Hannes; Sylvester, Karl G.; Thorgeirsson, Snorri S.; Grompe, Markus; Sage, Julien.

In: Journal of Experimental Medicine, Vol. 208, No. 10, 26.09.2011, p. 1963-1976.

Research output: Contribution to journalArticle

Viatour, P, Ehmer, U, Saddic, LA, Dorrell, C, Andersen, JB, Lin, C, Zmoos, AF, Mazur, PK, Schaffer, BE, Ostermeier, A, Vogel, H, Sylvester, KG, Thorgeirsson, SS, Grompe, M & Sage, J 2011, 'Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway', Journal of Experimental Medicine, vol. 208, no. 10, pp. 1963-1976. https://doi.org/10.1084/jem.20110198
Viatour, Patrick ; Ehmer, Ursula ; Saddic, Louis A. ; Dorrell, Craig ; Andersen, Jesper B. ; Lin, Chenwei ; Zmoos, Anne Flore ; Mazur, Pawel K. ; Schaffer, Bethany E. ; Ostermeier, Austin ; Vogel, Hannes ; Sylvester, Karl G. ; Thorgeirsson, Snorri S. ; Grompe, Markus ; Sage, Julien. / Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. In: Journal of Experimental Medicine. 2011 ; Vol. 208, No. 10. pp. 1963-1976.
@article{6cee295d963e41f29fe0ffe047934507,
title = "Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway",
abstract = "Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/ progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.",
author = "Patrick Viatour and Ursula Ehmer and Saddic, {Louis A.} and Craig Dorrell and Andersen, {Jesper B.} and Chenwei Lin and Zmoos, {Anne Flore} and Mazur, {Pawel K.} and Schaffer, {Bethany E.} and Austin Ostermeier and Hannes Vogel and Sylvester, {Karl G.} and Thorgeirsson, {Snorri S.} and Markus Grompe and Julien Sage",
year = "2011",
month = "9",
day = "26",
doi = "10.1084/jem.20110198",
language = "English (US)",
volume = "208",
pages = "1963--1976",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "10",

}

TY - JOUR

T1 - Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway

AU - Viatour, Patrick

AU - Ehmer, Ursula

AU - Saddic, Louis A.

AU - Dorrell, Craig

AU - Andersen, Jesper B.

AU - Lin, Chenwei

AU - Zmoos, Anne Flore

AU - Mazur, Pawel K.

AU - Schaffer, Bethany E.

AU - Ostermeier, Austin

AU - Vogel, Hannes

AU - Sylvester, Karl G.

AU - Thorgeirsson, Snorri S.

AU - Grompe, Markus

AU - Sage, Julien

PY - 2011/9/26

Y1 - 2011/9/26

N2 - Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/ progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.

AB - Hepatocellular carcinoma (HCC) is the third cancer killer worldwide with >600,000 deaths every year. Although the major risk factors are known, therapeutic options in patients remain limited in part because of our incomplete understanding of the cellular and molecular mechanisms influencing HCC development. Evidence indicates that the retinoblastoma (RB) pathway is functionally inactivated in most cases of HCC by genetic, epigenetic, and/or viral mechanisms. To investigate the functional relevance of this observation, we inactivated the RB pathway in the liver of adult mice by deleting the three members of the Rb (Rb1) gene family: Rb, p107, and p130. Rb family triple knockout mice develop liver tumors with histopathological features and gene expression profiles similar to human HCC. In this mouse model, cancer initiation is associated with the specific expansion of populations of liver stem/ progenitor cells, indicating that the RB pathway may prevent HCC development by maintaining the quiescence of adult liver progenitor cells. In addition, we show that during tumor progression, activation of the Notch pathway via E2F transcription factors serves as a negative feedback mechanism to slow HCC growth. The level of Notch activity is also able to predict survival of HCC patients, suggesting novel means to diagnose and treat HCC.

UR - http://www.scopus.com/inward/record.url?scp=80555154065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80555154065&partnerID=8YFLogxK

U2 - 10.1084/jem.20110198

DO - 10.1084/jem.20110198

M3 - Article

C2 - 21875955

AN - SCOPUS:80555154065

VL - 208

SP - 1963

EP - 1976

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 10

ER -